FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.09-133421.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.09-133421v1
23/9/2909    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Guillot, N.
Right arrow Articles by Véricel, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guillot, N.
Right arrow Articles by Véricel, E.
(The FASEB Journal. 2009;23:2909-2916.)
© 2009 FASEB

Increasing intakes of the long-chain {omega}-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men

Nicolas Guillot*,{dagger},{ddagger},§, Emilie Caillet*,{dagger},{ddagger},§, Martine Laville*,{dagger},{ddagger},§,||, Catherine Calzada*,{dagger},{ddagger},§, Michel Lagarde*,{dagger},{ddagger},§ and Evelyne Véricel*,{dagger},{ddagger},§,1

* Université de Lyon, Lyon, France;

{dagger} INSERM U870, IMBL, Villeurbanne, France;

{ddagger} INSA de Lyon, RMND, Villeurbanne, France;

§ INRA U1235, Oullins, France; and

|| CRNH-RA, Hospices Civils de Lyon, Lyon, France

1 Correspondence: INSERM U.870, INSA de Lyon, Régulations Métaboliques, Nutrition et Diabètes, Bât Louis Pasteur, IMBL, INSA, 20 Ave. Albert Einstein, 69621 Villeurbanne Cedex, France. E-mail: evelyne.vericel{at}insa-lyon.fr

Docosahexaenoic acid (DHA) can prevent cardiovascular events. However, few studies have addressed the effects of DHA on both platelet reactivity and redox status in healthy subjects, and dose-related studies are scarce. The main objectives of the present study were to determine the effects of increasing doses of DHA on platelets and redox status in humans. Twelve healthy male volunteers (aged 53–65 yr) were assigned to consume an intake of successively 200, 400, 800, and 1600 mg/d DHA, as the only {omega}-3 fatty acid, for 2 wk each dose. Blood and urine samples were collected before and after each dose of DHA and at 8 wk after arrest of supplementation. DHA was incorporated in a dose-response fashion in platelet phospholipids. After supplementation with 400 and 800 mg/d DHA, platelet reactivity was significantly decreased. Platelet vitamin E concentration increased only after 200 mg/d DHA, while p38 MAP kinase phosphorylation decreased. Urinary isoprostane was also significantly lowered after 200 mg/d DHA but was increased after 1600 mg/d. Therefore, supplementation with only 200 mg/d DHA for 2 wk induced an antioxidant effect. It is concluded that low consumption of DHA could be an effective and nonpharmacological way to protect healthy men from platelet-related cardiovascular events.—Guillot, N., Caillet, E., Laville, M., Calzada, C., Lagarde, M., Véricel, E. Increasing intakes of the long-chain {omega}-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men.


Key Words: arachidonic acid • isoprostane • oxidative stress • vitamin E







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.